BPG is committed to discovery and dissemination of knowledge
Articles in Press
10/5/2019 7:02:04 AM | Browse: 131 | Download: 21
Publication Name World Journal of Clinical Cases
Manuscript ID 50448
Country of Manuscript Source China
Specialty Obstetrics and Gynecology
Manuscript type Case Report
Article Title Apatinib treatment in a pseudomyxoma peritonei patient after surgical treatment and hyperthermic intraperitoneal chemotherapy: A case report
Manuscript Source Unsolicited Manuscript
All Author List Rong Huang, Xiu-Ling Shi, Yun-Fei Wang, Fei Yang, Ting-Tao Wang and Cun-Xu Peng
Funding Agency and Grant Number
Correspondence To Cun-Xu Peng, N/A, Doctor, Professor, Surgeon, Department of Gynecology, The Affiliated Hospital of Jining Medical University, Jining Medical University, 89 Guhuai Road, Jining 272000, Shandong Province, China. pengcunxu@aliyun.com
Keywords Pseudomyxoma peritonei; Abdominal distention; Anti-angiogenic agent; Apatini; Case report; -
Core Tip The preferred treatment for pseudomyxoma peritonei (PMP) is surgery, but it is easy to relapse after surgery. There is currently no good treatment for patients with postoperative recurrence. In this work,the PMP patient received apatinib for recurrent abdominal distension after surgical treatment and hyperthermic intraperitoneal chemotherapy. After treatment with apatinib, the recurrence time was significantly prolonged. Apatinib, a small-molecule oral inhibitor with anti-angiogenic function, may be an option for recurrent PMP after surgical treatment.
Citation Huang R, Shi XL, Wang YF, Yang F, Wang TT, Peng CX. Apatinib treatment in a pseudomyxoma peritonei patient after surgical treatment and hyperthermic intraperitoneal chemotherapy: A case report. World J Clin Cases 2019; In press
Received
2019-07-20 13:40
Peer-Review Started
2019-07-23 03:12
To Make the First Decision
2019-09-16 03:55
Return for Revision
2019-09-17 02:49
Revised
2019-09-17 15:29
Second Decision
2019-09-25 08:44
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-10-05 07:02
Articles in Press
2019-10-05 07:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
2019-10-07 03:29
Typeset the Manuscript
ISSN 2307-8960 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Assistant Editor Assistant Editor
Science Editor Na Ma
Reviewer Code 00724702, and 00009760
Editorial Director Jin-Lei Wang
Journal Chief Editor
Company Chief Editor Lian-Sheng Ma
Language Editor Tian-Qi Wang
Electronic Editor
Responsible Electronic Editor
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma
Manuscript File 50448-Review_Edited.docx
Answering Reviewers 50448-Answering reviewers.pdf
Audio Core Tip 50448-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 50448-Conflict-of-interest statement.pdf
Copyright License Agreement 50448-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 50448-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 50448-Language certificate.pdf
Peer-review Report 50448-Peer-review(s).pdf
Scientific Misconduct Check 50448-Scientific misconduct check.pdf
Scientific Editor Work List 50448-Scientific editor work list.pdf